HIV/AIDS
Conditions
Interventions
Oral PrEP Dapivirine Ring Injectable Cabotegravir and technical support
Oral PrEP will be available during control period
Sponsors
National Institute of Health
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: - Age =18 years and =30years. - Seeking a reproductive health service from one of the project facilities (reproductive health services include but are not limited to family planning, maternal and child health, postnatal care). - AGYW receiving reproductive health-related services through OPD, or other departments are eligible. • Willing and able to partake in an informed consent process. • Able to speak and read in Kiswahili or English
Exclusion criteria
Exclusion criteria: - Under age 18 or above age 30 • Seeking a service that is not related to reproductive health care. • Investigator determination that the AGYW should not participate in the research. • Unable to speak and read in Kiswahili or English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes are PrEP uptake and 3-month persistence, which will be ascertained through data abstraction of facility records, primarily the PrEP client record that is a Ministry of Health tool. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes include 1) 6-month PrEP persistence, 2) PrEP adherence at month 3 which will be measured objectively on research participants via tenofovir-diphosphate levels in those using oral PrEP, DPV residual levels in those using DPV ring, and injection records (from the PrEP client card) among those using injectable CAB, and 3) sexual behavior measured through self-report on research questionnaires. | — |
Countries
Kenya
Contacts
Public ContactCatherine Kiptinness
Site Coordinator at Partners in Health and Research Development KEMRI
Outcome results
None listed